Emergency Use Authorities (including stockpiler-initiated) In addition to SLEP, there are other ways that, when appropriate, FDA can allow certain medical products to be used beyond their manufacturer-labeled expiration dates
Slowly tapering off the medication is the best way to reduce the effects of stopping
Fenofibrate, a PPAR a agonist, may convey benefit but further studies are required
Amycretin, a single molecule that combines GLP-1 and amylin activity in both oral and injectable forms, and survodutide, a GLP-1 and glucagon agonist aimed heavily at liver disease, have both advanced into Phase 3
Guidelines for using Bsoft for high resolution reconstruction and validation of biomolecular structures from electron micrographs